Vision Research in Europe

New antibody therapy may reverse diabetic retinopathy and other eye conditions

The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy - a protein to treat disease. A century later, a new biologic therapy also developed by researchers at U of T has potential to reverse a common complication of diabetes.
» New antibody therapy may reverse diabetic retinopathy and other eye conditions

Sharp vision with exchanged eye lens: LZH works on improved lens refilling

In eye surgery for cataract, the lens refilling method could allow to maintain or restore the lens's accommodation of the lens, i.e. the ability to adjust its refractive power flexibly. So far, however, this method has not yet been clinically successful. The Laser Zentrum Hannover e.V. (LZH) is now...
» Sharp vision with exchanged eye lens: LZH works on improved lens refilling

New analysis tool of microscopic images with Deepflash

Information technology can make life easier in many areas – including research. In medicine, for example, it is still standard practice to evaluate microscopy images of tissue sections by hand. Microscopic images of tissue sections can now be analyzed much more easily – with an innovative digital...
» New analysis tool of microscopic images with Deepflash

Development of Artificial Intelligence for the Management of Retinal Diseases

New Christian Doppler Laboratory opened at MedUni Vienna
» Development of Artificial Intelligence for the Management of Retinal Diseases

Age-Related Macular Degeneration Revisited in Nature Reviews Disease Primers

An international collaboration of scientists publishing in Nature Reviews Disease Primers advocate for a new way of thinking about and finding treatments for age-related macular degeneration (AMD)—the developed world’s leading cause of severe vision impairment for people aged 55 and older.
» Age-Related Macular Degeneration Revisited in Nature Reviews Disease Primers

Optogenetic Methods Restore Partial Vision in a Blind Patient

An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that could restore vision.
» Optogenetic Methods Restore Partial Vision in a Blind Patient

Visionary of the Quarter

Young Researcher in Focus

Read more about Arne F. Meyer and his work in the field of vision research.

Latest News

Gene therapy for common forms of congenital blindness shows promise to improve vision

A new gene therapy for one of the most common... Read more

Researchers grow stem cells to cure glaucoma

A joint research effort carried out by MIPT... Read more

Nanoscope presents optical gene delivery

Nanoscope Technologies LLC, a biotechnology... Read more

Glaukos Expands its Preserflo MicroShunt Relationship With Santen via New License Agreement

Glaukos announced that it has entered into a new... Read more

Good research begins long before papers get written

Publishers are redoubling their commitment to... Read more

‘Hybrid’ scientific conferences aim to offer the best of in-person and virtual meetings

Last year, the COVID-19 pandemic upended the... Read more

Even in a pandemic, child vision tests are crucial

It's critical for parents to maintain their... Read more

FDA Approves Bausch + Lomb ClearVisc Dispersive Ophthalmic Viscosurgical Device (OVD)

Bausch + Lomb, announced that the FDA has approved... Read more

New mechanism identified behind blindness in older adults

Using laboratory-grown roundworms as well as human... Read more

Scientists develop AI platform to assess blood vessel anomalies and eye disease

An international team of scientists from Nanyang... Read more

Events

According to the worlwide COVID 19 pandemic severe changes in upcoming events are possible - please inform yourself carefully at the respective host website

Advertising banner